Prothena Corp Public Ltd Co financial data

Symbol
PRTA on Nasdaq
Industry
Pharmaceutical Preparations
Location
77 Sir John Rogerson's Quay, Block C, Grand Canal Docklands, Dublin 2, Ireland
State of incorporation
Ireland
Fiscal year end
December 31
Former names
Prothena Corp plc (to 5/22/2020), Neotope Corp Ltd (to 10/1/2012)
Latest financial report
10-K - Q4 2024 - Feb 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.17K % +0.1%
Debt-to-equity 14.5 % -36.1%
Return On Equity -23.2 % +6.44%
Return On Assets -20.3 % -0.25%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 53.8M shares +0.1%
Common Stock, Shares, Outstanding 53.8M shares +0.27%
Entity Public Float 870M USD -70%
Common Stock, Value, Issued 538K USD +0.19%
Weighted Average Number of Shares Outstanding, Basic 53.8M shares +1.05%
Weighted Average Number of Shares Outstanding, Diluted 53.8M shares +1.05%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 135M USD +47.9%
Research and Development Expense 223M USD +0.88%
General and Administrative Expense 67.2M USD +8.68%
Operating Income (Loss) -155M USD +19.1%
Nonoperating Income (Expense) 25.6M USD -16.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -129M USD +19.7%
Income Tax Expense (Benefit) -6.62M USD +50.8%
Net Income (Loss) Attributable to Parent -122M USD +16.8%
Earnings Per Share, Basic -2.27 USD/shares +17.8%
Earnings Per Share, Diluted -2.27 USD/shares +17.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 471M USD -23.8%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Assets, Current 485M USD -24.1%
Deferred Income Tax Assets, Net 43.2M USD +27.6%
Property, Plant and Equipment, Net 3.08M USD -19.7%
Operating Lease, Right-of-Use Asset 10.7M USD -12%
Other Assets, Noncurrent 3.81M USD -40%
Assets 547M USD -21.4%
Accounts Payable, Current 7.77M USD -69.4%
Employee-related Liabilities, Current 14.5M USD +9.23%
Liabilities, Current 48.5M USD -14.7%
Operating Lease, Liability, Noncurrent 8.23M USD -23.2%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 60.2M USD -55.4%
Retained Earnings (Accumulated Deficit) -1.1B USD -12.5%
Stockholders' Equity Attributable to Parent 487M USD -13.3%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 487M USD -13.3%
Liabilities and Equity 547M USD -21.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -73.1M USD -53.9%
Net Cash Provided by (Used in) Financing Activities 836K USD -96.4%
Net Cash Provided by (Used in) Investing Activities -103K USD -115%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 53.8M shares +0.27%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 472M USD -24%
Deferred Tax Assets, Valuation Allowance 199M USD +9.44%
Deferred Tax Assets, Gross 245M USD +11.9%
Operating Lease, Liability 10.8M USD
Depreciation 900K USD 0%
Lessee, Operating Lease, Liability, to be Paid 12.1M USD -18.2%
Property, Plant and Equipment, Gross 11.4M USD +1.23%
Operating Lease, Liability, Current 2.61M USD +134%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.16M USD +3.47%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.18M USD +12.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.29M USD -57.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.27M USD +3.52%
Deferred Tax Assets, Operating Loss Carryforwards 171M USD +9.71%
Unrecognized Tax Benefits 15.4M USD +15.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.52M USD -22.8%
Operating Lease, Payments 0 USD -100%
Additional Paid in Capital 1.59B USD +3.11%
Depreciation, Depletion and Amortization 215K USD +6.97%
Deferred Tax Assets, Net of Valuation Allowance 46M USD +24.1%